Skip to Content
Merck
  • Intraovarian transplantation of primordial follicles fails to rescue chemotherapy injured ovaries.

Intraovarian transplantation of primordial follicles fails to rescue chemotherapy injured ovaries.

Scientific reports (2013-03-07)
Mi-Ryung Park, Yun-Jung Choi, Deug-Nam Kwon, Chankyu Park, Hong-Thuy Bui, Sangiliyandi Gurunathan, Ssang-Goo Cho, Hyuk Song, Han Geuk Seo, Gyesik Min, Jin-Hoi Kim
ABSTRACT

Busulfan and cyclophosphamide (B/C)-treated mice exhibited a marked increase in apoptosis and a concomitant decrease in the ovarian weight. Histological and RT-PCR analysis indicate that the period of germ cell depletion in the B/C-treated ovaries coincides with decreased expression of genes Figla, Lhx8, Nobox, c-kit, and Sox3. However, depletion of the ovarian germ cells is mediated by autophagy-independent pathways that involve Fas/FasL-, TNF-, and/or p53-signalings. Treatment with B/C resulted in the cease of the reproductive function to produce their offspring during the 15(th) week post-treatment period in female mice. Furthermore, injection of the 3 × 10(6) GFP positive primordial follicles into the ovaries of the B/C treated mouse did not show apparent colonization of the transplanted follicles within the recipient ovaries. The present results suggest that B/C treatment is closely associated with an increased risk of premature ovarian failure.

MATERIALS
Product Number
Brand
Product Description

Supelco
Busulfan, analytical standard, for drug analysis
Busulfan, European Pharmacopoeia (EP) Reference Standard